Latest market price
86.62
+1.74+2.05%
HSICQT67Henry Schein, Inc.·NASDAQ
86.62+2.05%
TA
Loading chart...
Screen all →
Snapshot
IndexS&P 500P/E25.25EPS (ttm)3.43Insider Own5.63%Shs Outstand111.45MPerf Week2.50%
Market Cap9.65BForward P/E14.46EPS next Y5.99Insider Trans0.16%Shs Float91.71MPerf Month2.05%
Enterprise Value13.23BPEG2.67EPS next Q1.36Short Float9.82%Perf Quarter-2.79%
Income403.00MP/S0.71EPS this Y9.55%Short Ratio7.55Perf Half Y20.27%
Sales13.60BP/B2.04EPS next Y11.13%ROA3.54%Short Interest9.01MPerf YTD14.61%
Book/sh42.38P/C61.49EPS next 5Y9.44%ROE12.37%52W High92.18 -6.03%Perf Year37.71%
Cash/sh1.41P/FCF17.91EPS past 3/5Y-5.78% 3.15%ROIC6.47%52W Low62.44 38.73%Perf 3Y30.24%
Dividend Est.—EV/EBITDA12.66Sales past 3/5Y1.40% 5.43%Gross Margin30.31%Volatility2.18% 2.28%Perf 5Y13.66%
Dividend TTM—EV/Sales0.97EPS Y/Y TTM10.65%Oper. Margin5.69%ATR (14)1.92Perf 10Y44.80%
Dividend Ex-Date—Quick Ratio0.73Sales Y/Y TTM6.49%Profit Margin2.96%RSI (14)54.51Recom2.59
Dividend Gr. 3/5Y—Current Ratio1.32EPS Q/Q15.45%SMA201.81%Beta0.84Target Price95.44
Payout0.00%Debt/Eq0.79Sales Q/Q6.73%SMA500.15%Rel Volume2.20Prev Close84.88
Employees25,000LT Debt/Eq0.55EarningsNov 03SMA2006.80%Avg Volume1.14MPrice86.62
IPO DateNov 03, 1995Option/ShortYes / YesEPS/Sales Surpr.2.46% 2.49%Net Debt/EBITDA3.43Volume2,501,792Change2.05%
Analyst Ratings
DateActionAnalystRatingTarget
Oct-14-26ReiteratedLeerink PartnersMarket Perform$87 → $92
Aug-19-26ReiteratedBTIGBuy$100 → $110
Aug-06-26ReiteratedBarclaysOverweight$86 → $100
Aug-05-26ReiteratedBarringtonOutperform$97 → $104
Aug-05-26ReiteratedStifel NicolausHold$84 → $95
Aug-05-26ReiteratedUBSNeutral$89 → $94
Jul-28-26ReiteratedUBSNeutral$85 → $89
Jul-08-26InitiatedBMO CapitalMarket Perform$85
Jun-11-26UpgradeBTIGNeutral → Buy$100
May-06-26ReiteratedRobert W. Baird$104 → $97
Latest News· Times ET
Oct-30-26
Oct-27-26
Oct-20-26
Oct-19-26
Oct-14-26
Oct-08-26
Oct-06-26
Sep-30-26
Sep-23-26
Company

Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/27/2025
FY 2024
12/28/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue13,60213,18412,67312,339—————
Cost of Goods Sold Incl. D&A9,4799,3428,9088,688—————
Gross Profit4,1233,8423,7653,651—————
Selling, General and Administrative Excl. Other3,2003,0843,0362,937—————
Research and Development
0000—————
Other Operating Expense
149000—————
Operating Income774758729714—————
Interest Expense15915013187—————
Unusual Expense
—————————
Non-Operating Income (Expense)-57-63-72-71—————
Net Income Before Taxes558545526556—————
Income Taxes132126128120—————
Consolidated Net Income403398390416—————
Net Income From Continuing Operations426419398436—————
Net Income403398390416—————
EPS (Recurring)3.463.293.073.18—————
EPS (Basic, Before Extraordinaries)3.463.293.073.18—————
EPS (Diluted)3.433.273.053.16—————
EBITDA1,0451,006912851—————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio25.2523.2823.0923.96—————
Price To Sales Ratio0.720.700.710.80—————
Gross Margin30.3129.1429.7129.59—————
Operating Margin5.695.755.755.79—————
Net Margin2.963.023.083.37—————
Shares Outstanding113121127131—————
Market Capitalization9,7889,2128,9439,918—————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$95.18$85.81$76.44$67.08$57.71● Close Price0.00M1.15M2.30M3.44M4.59MUSD Trades VolumeNovDec2026FebMarAprMayJunJulAugSepOctNov
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
DANIEL WILLIAM KDirectorMay 11 '26Buy69.1910,000691,90020,000May 12
Popeck Thomas CCEO, Henry Schein ProductsMar 19 '26Sale72.791,35598,63086,182Mar 20
KUEHN KURT PDirectorMar 10 '26Sale78.962,844224,56515,420Mar 11
LASKAWY PHILIP ADirectorMar 05 '26Sale80.362,844228,54421,961Mar 06
MLOTEK MARK EEVP, Chief Strategic OfficerMar 04 '26Sale80.805,925478,74080,554Mar 06
BERGMAN STANLEY MChairman, CEOMar 02 '26Sale81.3143,8123,562,354383,803Mar 03
BERGMAN STANLEY MChairman, CEOFeb 27 '26Sale81.2010,785875,742309,092Feb 27
BERGMAN STANLEY MChairman, CEOFeb 26 '26Sale81.0138,3463,106,591427,615Feb 27
DANIEL WILLIAM KDirectorAug 07 '25Buy67.0810,000670,80010,000Aug 11
LASKAWY PHILIP ADirectorMar 19 '25Sale71.042,604184,99924,805Mar 20
Connett Bradford CCEO, NA Distribution GroupMar 19 '25Sale71.154,036287,16162,688Mar 20
KUEHN KURT PDirectorMar 05 '25Sale71.552,787199,39615,687Mar 06
Ettinger Michael SEVP & Chief Operating OfficerNov 18 '24Sale75.0012,240918,00087,706Nov 20
McGlynn LoreleiSVP, Chief Human Res. OfficerSep 06 '24Sale69.3021,0351,457,72671,833Sep 09
MLOTEK MARK EEVP, Chief Strategic OfficerAug 14 '24Sale69.123,000207,36087,851Aug 15
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.